Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06243133
PHASE4

Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis

Sponsor: Sichuan Provincial People's Hospital

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn about efficacy and safety of dual antiplatelet therapy in ischemic stroke with intracranial artery stenosis. The main question it aims to answer are: whether aspirin combined with clopidogrel for 3 month is better than 1 months for patients with non-cardiogenic cerebral infarction with intracranial artery stenosis. Participants will get dual antiplatelet therapy (aspirin plus clopidogrel) for 1 month or 3 months within 7 days of the first stroke. Researchers will compare experimental group (3 months dual antiplatelet therapy) with comparison group (1 month dual antiplatelet therapy), to see if experimental group would reduce stroke recurrence or mortality, and increase bleeding and other adverse prognosis.

Key Details

Gender

All

Age Range

40 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

1100

Start Date

2024-07-01

Completion Date

2026-03-31

Last Updated

2024-06-18

Healthy Volunteers

No

Interventions

DRUG

clopidogrel for 90 days combined with aspirin for 90 days

Clopidogrel 300mg on the first day, then 75mg/day for 90 consecutive days; Aspirin 100mg/day for 90 days

DRUG

clopidogrel for 30 days combined with aspirin for 90 days

Clopidogrel 300mg on the first day, then 75mg/ day for 30 consecutive days; Aspirin 100mg/ day for 90 days

Locations (1)

Sichuan Provincial People's Hospital

Chengdu, Sichuan, China